R&D | April 22, 2026
Leinco and CellCarta team up to power next-gen proteomics for cancer and targeted therapies
Together, the companies aim to deliver an integrated toolkit for biomarker discovery and clinical research
Together, the companies aim to deliver an integrated toolkit for biomarker discovery and clinical research
The combined offering is designed to support a wide range of applications, from pilot-scale research to high-volume clinical use
These findings help explain how relapse-triggering memories can persist alongside those that support recovery
Pharma giant targets new standards of care
The event showcased latest breakthroughs in minimally invasive surgery, organ-preservation strategies, and targeted therapies
The presentations will showcase previously undisclosed data highlighting the expanding potential of Actinium’s Ac-225 radiotherapy platform across both solid tumors and hematologic malignancies
Lonza will take on technology transfer, process optimization, and cGMP manufacturing, leveraging its global network and expertise in highly potent compounds
The study included four independent genetic substudies targeting obesity caused by heterozygous variants in the POMC/PCSK1, LEPR, SRC1 (NCOA1), and SH2B1 genes
The drug’s safety profile in LIBRETTO-432 aligned with previous selpercatinib studies, showing no unexpected concerns
The agreement ensures BIOEMTECH customers can consistently obtain Ac-225 for preclinical studies
Subscribe To Our Newsletter & Stay Updated
